Recruiting

Observational Study

Sponsor:

LASARRUS Clinic and Research Center

Code:

NCT06751537

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Eligibility Criteria

Sex: All

Age: 21 - 70+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

This observational study evaluates the effectiveness of the WearME system in monitoring COPD severity and respiratory function by comparing its measurements to standard spirometry, capnography, and other clinical assessments in 128 COPD participants.

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Study ID

NCT06751537

Start date

May 29, 2025

Status verified date

Sep, 2025

Completion date

Feb 28, 2026

Anticipated

Primary completion date

Jan 31, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 21 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Adult participants aged 21-100 years, of any sex, and of any race/ethnicity, who are able to understand and sign consent documents in English or Spanish.
  • Diagnosed with COPD as per the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria \[5\] , with the following severity levels (confirmed via spirometry performed after consent):

  • Mild: FEV1/FVC < 0.7 and FEV1 ≥ 80%
  • Moderate: FEV1/FVC < 0.7 and 50% ≤ FEV1 < 80%
  • Severe: FEV1/FVC < 0.7 and 30% ≤ FEV1 < 50%
  • Very Severe: FEV1/FVC < 0.7 and FEV1 < 30% or FEV1 < 50%, plus chronic respiratory failure.

Note: Participants will be consented and enrolled based on prior diagnosis of COPD from medical records within the past year to confirm eligibility and stratify COPD severity levels. Spirometry will be performed during concurrent data collection with the WearME device for comparison. Screening failures are expected and will be recorded and managed appropriately.

  • Current, former, or never smoker; any amount of time between quitting and study enrollment is allowed).
  • Ability to understand and willingness to sign consent documents.
  • Able to participate in study procedures as required.

Exclusion Criteria:

  • Participants with known skin allergies or conditions that may interfere with device application or signal transmission.
  • Currently receiving invasive mechanical ventilation.

Study Design

Enrollment

128 participants

Anticipated

Interventions and Outcome Measures

Arms

COPD Participants

Participants are wearing the WearME device and undergoing reference testing

Primary outcome measure

  • Agreement between WearME-Pro system and gold standard devices for FEV1 measurements, stratified by COPD severity. [ Time Frame: Within 6 months of study start. ]

Central Contacts and Locations

Central contacts

Locations

Johns Hopkins

Recruiting

Baltimore, Maryland, United States, 21224

Contacts

Chathurangi Pathiravasan, PhD

617-416-6222cpathir1@jh.edu

TidalHealth

Recruiting

Salisbury, Maryland, United States, 21801

Contacts

Principal Investigator:

Robert T Chasse, MD

More Information

Sponsor

LASARRUS Clinic and Research Center

Last update posted

Sep 9, 2025

Last verified

Sep, 2025

Keywords

  • lung function
  • respiratory rate
  • FEV1
  • FVC
  • I:E ratio
  • Pulmonary Devices
  • Machine Learning

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by LASARRUS Clinic and Research Center on 2025-09-09.